These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 9337440

  • 1. Pharmacokinetics of methotrexate in plasma and cerebrospinal fluid.
    Morikawa N, Mori T, Abe T, Ghoda M, Takeyama M, Hori S.
    Ann Pharmacother; 1997 Oct; 31(10):1153-6. PubMed ID: 9337440
    [Abstract] [Full Text] [Related]

  • 2. Dose-related increases in cerebrospinal fluid concentrations of methotrexate in a postoperative patient with glioblastoma.
    Morikawa N, Mori T, Kamenofuchi Y, Kawashima H, Takeyama M, Hori S.
    Ann Pharmacother; 1999 Sep; 33(9):952-6. PubMed ID: 10492499
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma.
    Zylber-Katz E, Gomori JM, Schwartz A, Lossos A, Bokstein F, Siegal T.
    Clin Pharmacol Ther; 2000 Jun; 67(6):631-41. PubMed ID: 10872645
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of etoposide and carboplatin in cerebrospinal fluid and plasma during hyperosmotic disruption of the blood brain barrier and intraarterial combination chemotherapy.
    Morikawa N, Mori T, Abe T, Kawashima H, Takeyama M, Hori S.
    Biol Pharm Bull; 1999 Apr; 22(4):428-31. PubMed ID: 10328568
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of anticancer drugs in cerebrospinal fluid.
    Morikawa N, Mori T, Kawashima H, Takeyama M, Hori S.
    Ann Pharmacother; 1998 Oct; 32(10):1008-12. PubMed ID: 9793590
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of nimustine, cytosine arabinoside, and methotrexate in cerebrospinal fluid during cerebrospinal fluid perfusion chemotherapy.
    Morikawa N, Mori T, Kawashima H, Takeyama M, Abe T, Kobayashi H.
    Biol Pharm Bull; 2001 Apr; 24(4):436-8. PubMed ID: 11305611
    [Abstract] [Full Text] [Related]

  • 10. Effect of probenecid on ventricular cerebrospinal fluid methotrexate pharmacokinetics after intralumbar administration in nonhuman primates.
    Salzer W, Widemann B, McCully C, Adamson PC, Balis FM.
    Cancer Chemother Pharmacol; 2001 Sep; 48(3):235-40. PubMed ID: 11592346
    [Abstract] [Full Text] [Related]

  • 11. Methotrexate-vindesine association in leukemia: pharmacokinetic study.
    Tubiana N, Lena N, Barbet J, Imbert AM, Lejeune C, Maraninchi D, Sainty D, Sebahoun G, Gastaut JA, Cano JP.
    Med Oncol Tumor Pharmacother; 1985 Sep; 2(2):99-102. PubMed ID: 3864001
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of tumor cell exposure to [14C]methotrexate after intracarotid administration without and with hyperosmotic opening of the blood-brain and blood-tumor barriers in rat brain tumors: a quantitative autoradiographic study.
    Shapiro WR, Voorhies RM, Hiesiger EM, Sher PB, Basler GA, Lipschutz LE.
    Cancer Res; 1988 Feb 01; 48(3):694-701. PubMed ID: 3335031
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Safety and pharmacokinetic analysis of methotrexate administered directly into the fourth ventricle in a piglet model.
    Sandberg DI, Solano J, Petito CK, Mian A, Mou C, Koru-Sengul T, Gonzalez-Brito M, Padgett KR, Luqman A, Buitrago JC, Alam F, Wilkerson JR, Crandall KM, Kuluz JW.
    J Neurooncol; 2010 Dec 01; 100(3):397-406. PubMed ID: 20440538
    [Abstract] [Full Text] [Related]

  • 15. PBPK model of methotrexate in cerebrospinal fluid ventricles using a combined microdialysis and MRI acquisition.
    Brandhonneur N, Noury F, Bruyère A, Saint-Jalmes H, Le Corre P.
    Eur J Pharm Biopharm; 2016 Jul 01; 104():117-30. PubMed ID: 27142258
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of nimustine, methotrexate, and cytosine arabinoside during cerebrospinal fluid perfusion chemotherapy in patients with disseminated brain tumors.
    Morikawa N, Mori T, Kawashima H, Fujiki M, Abe T, Kaku T, Konisi Y, Takeyama M, Hori S.
    Eur J Clin Pharmacol; 1998 Jul 01; 54(5):415-20. PubMed ID: 9754986
    [Abstract] [Full Text] [Related]

  • 17. [Intra-arterial infusion of high dose methotrexate therapy in recurrent gliomas].
    Hayashi A, Kyuma Y.
    Gan To Kagaku Ryoho; 1990 Aug 01; 17(8 Pt 1):1461-6. PubMed ID: 2117886
    [Abstract] [Full Text] [Related]

  • 18. Probenecid inhibition of methotrexate-cerebrospinal fluid pharmacokinetics in dogs.
    Ramu A, Fusner JE, Blaschke T, Glaubiger DL.
    Cancer Treat Rep; 1978 Oct 01; 62(10):1465-70. PubMed ID: 581360
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.